Mapping breast cancer journal publications in conflict settings in the MENA region: a scoping review.
breast cancer
conflict
research capacity
Journal
Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
06
2020
entrez:
19
11
2020
pubmed:
20
11
2020
medline:
20
11
2020
Statut:
epublish
Résumé
Breast cancer is a major cause of cancer-related morbidity and mortality among women in the the Middle East and North Africa (MENA) region. Conflict and political instability in the region may affect medical research output, including that on breast cancer. This scoping review aims to systematically identify and map breast cancer publications across different stages of the cancer care pathway and across conflict-affected countries within the MENA region. The findings of this work will highlight the impact of conflict on cancer research that could be mitigated with the proper contextualised capacity strengthening intervention. We followed the PRISMA-Scr methodology. We searched for peer-reviewed publications on topics related to breast cancer in 11 databases: Medline, PubMed, EMBASE, Web of Science, PROQUEST, CINAHL, Global Index Medicus, Arab World Searches Complete, Popline, Scopus and Google Scholar using both controlled vocabulary and keywords. Publication abstracts and full-text versions were screened for duplicates and included in our study based on pre-specified eligibility criteria: focused on breast cancer, related to the specific country of analysis and human or health system studies. We used a structured data extraction form to extract information related to the article, its methodology and the cancer care pathway being studied. A total of 19,215 citations were retrieved from our search. After removing duplicates, a total of 8,622 articles remained. Title and abstract screening retained 1,613 articles. Publications with first author affiliations to Turkey were consistently the highest across all categories of the cancer care pathway. Trends show an increase in articles from Lebanon, Jordan and Palestine after 2015. Early exploratory and epidemiological studies represented the majority of breast cancer research, followed by policy and implementation research and lastly experimental research. Most research conducted followed an observational study design. Important gaps were identified in the research output related to advanced breast cancer and palliative care (Libya, Syria and Yemen), mental health (Libya), and knowledge and education of breast cancer (Libya and Syria). This scoping review has identified key areas in breast cancer research that lack significant research activity in conflict MENA settings. These areas, including but are not limited to palliative care, mental health, and education, can be prioritised and developed through regional collaboration and contextualised capacity strengthening initiatives.
Sections du résumé
BACKGROUND
BACKGROUND
Breast cancer is a major cause of cancer-related morbidity and mortality among women in the the Middle East and North Africa (MENA) region. Conflict and political instability in the region may affect medical research output, including that on breast cancer. This scoping review aims to systematically identify and map breast cancer publications across different stages of the cancer care pathway and across conflict-affected countries within the MENA region. The findings of this work will highlight the impact of conflict on cancer research that could be mitigated with the proper contextualised capacity strengthening intervention.
METHODS
METHODS
We followed the PRISMA-Scr methodology. We searched for peer-reviewed publications on topics related to breast cancer in 11 databases: Medline, PubMed, EMBASE, Web of Science, PROQUEST, CINAHL, Global Index Medicus, Arab World Searches Complete, Popline, Scopus and Google Scholar using both controlled vocabulary and keywords. Publication abstracts and full-text versions were screened for duplicates and included in our study based on pre-specified eligibility criteria: focused on breast cancer, related to the specific country of analysis and human or health system studies. We used a structured data extraction form to extract information related to the article, its methodology and the cancer care pathway being studied.
RESULTS
RESULTS
A total of 19,215 citations were retrieved from our search. After removing duplicates, a total of 8,622 articles remained. Title and abstract screening retained 1,613 articles. Publications with first author affiliations to Turkey were consistently the highest across all categories of the cancer care pathway. Trends show an increase in articles from Lebanon, Jordan and Palestine after 2015. Early exploratory and epidemiological studies represented the majority of breast cancer research, followed by policy and implementation research and lastly experimental research. Most research conducted followed an observational study design. Important gaps were identified in the research output related to advanced breast cancer and palliative care (Libya, Syria and Yemen), mental health (Libya), and knowledge and education of breast cancer (Libya and Syria).
CONCLUSION
CONCLUSIONS
This scoping review has identified key areas in breast cancer research that lack significant research activity in conflict MENA settings. These areas, including but are not limited to palliative care, mental health, and education, can be prioritised and developed through regional collaboration and contextualised capacity strengthening initiatives.
Identifiants
pubmed: 33209120
doi: 10.3332/ecancer.2020.1129
pii: can-14-1129
pmc: PMC7652545
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1129Informations de copyright
© the authors; licensee ecancermedicalscience.
Déclaration de conflit d'intérêts
All authors have no conflicts of interest.
Références
Int J Surg. 2007 Aug;5(4):225-33
pubmed: 17660128
SICOT J. 2017;3:6
pubmed: 28134090
BMC Womens Health. 2015;15:25
pubmed: 25783656
Lancet Oncol. 2013 Sep;14(10):e417-24
pubmed: 23993386
Bull World Health Organ. 2004 Oct;82(10):764-70
pubmed: 15643798
Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):245-250
pubmed: 30626231
J Clin Oncol. 2009 Oct 20;27(30):5109-14
pubmed: 19720905
J Palliat Med. 2016 Sep;19(9):957-63
pubmed: 27228478
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Glob Health. 2018 Dec;8(2):020411
pubmed: 30410737
Implement Sci. 2012 Jan 11;7:2
pubmed: 22236561
East Mediterr Health J. 2001 Nov;7(6):1012-6
pubmed: 15332743
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Breast J. 2015 Jan-Feb;21(1):111-8
pubmed: 25444441
Medicina (Kaunas). 2019 Aug 10;55(8):
pubmed: 31405167
Asian Pac J Cancer Prev. 2010;11(6):1731-9
pubmed: 21338224
J Glob Oncol. 2018 Jul;4:1-16
pubmed: 30085889
Syst Rev. 2013 Apr 08;2:20
pubmed: 23566447
Sultan Qaboos Univ Med J. 2017 May;17(2):e147-e154
pubmed: 28690885
J Med Liban. 2013 Oct-Dec;61(4):204-9
pubmed: 24428074
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
BMJ Glob Health. 2019 Nov 11;4(6):e001870
pubmed: 31798999
J Glob Oncol. 2016 Mar 16;2(5):255-258
pubmed: 28717711
Clin Oncol (R Coll Radiol). 2020 Jan;32(1):e16-e18
pubmed: 31358346
Breast. 2011 Apr;20 Suppl 2:S20-9
pubmed: 21376593
J Egypt Public Health Assoc. 2002;77(3-4):329-45
pubmed: 17216966
J Med Liban. 2002 Jan-Apr;50(1-2):3-9
pubmed: 12841305